SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study
- PMID: 34616616
- PMCID: PMC8459728
- DOI: 10.7717/peerj.12149
SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: adult population-based cross-sectional study
Abstract
Background: There are several ecological studies, but few studies of the prevalence of SARS-COV-2 at high altitude. We aimed to estimate the population-based seroprevalence of SARS-COV-2 in three settings of Cusco at the end of the first wave among adults.
Methods: A population-based survey was conducted in September 2020, in three settings in the region of Cusco: (1) Cusco city at 3,300 meters above the sea level (m.a.s.l.), (2) the periphery of Cusco (Santiago, San Jerónimo, San Sebastián, and Wanchaq) at 3,300 m.a.s.l., and (3) Quillabamba city, located at 1,050 m.a.s.l. People aged ≥ 18 years within a family unit were included. The diagnosis of SARS-CoV-2 infection was based on identifying anti- SARS-CoV-2 total antibodies (IgM and IgG) in serum using the Elecsys Anti-SARS-CoV-2 chemiluminescence test.
Results: We enrolled 1924 participants from 712 families. Of the total, 637 participants were anti-SARS-CoV-2 seropositive. Seroprevalence was 38.8% (95% CI [33.4%-44.9%]) in Cusco city, 34.9% (95% CI [30.4%-40.1%]) in the periphery of Cusco, and 20.3% (95% CI [16.2%-25.6%]) in Quillabamba. In 141 families (19.8%; 95% CI [17.0%-22.8%]) the whole members were positive to the test. Living with more than three persons in the same house, a positive COVID-19 case at home, and a member who died in the last five months were factors associated with SARS-COV-2 seropositivity. Dysgeusia/dysosmia was the symptom most associated with seropositivity (aPR = 2.74, 95% CI [2.41-3.12]); whereas always wearing a face shield (aPR = 0. 73; 95% CI [0.60-0.89]) or a facial mask (aPR = 0.76, 95% CI [0.63-0. 92) reduced that probability.
Conclusions: A great proportion of Cusco's city inhabitants presented anti-SARS-CoV-2 antibodies at the end of the first wave, with significant differences between settings. Wearing masks and face shields were associated with lower rate of seropositivity; however, efforts must be made to sustain them over time since there is still a high proportion of susceptible people.
Keywords: Altitude; COVID; Peru; Seroprevalence.
©2021 Huamani et al.
Conflict of interest statement
The authors declare there are no competing interests.
Figures

Similar articles
-
Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru.Glob Epidemiol. 2023 Dec 17;7:100131. doi: 10.1016/j.gloepi.2023.100131. eCollection 2024 Jun. Glob Epidemiol. 2023. PMID: 38188037 Free PMC article.
-
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru.EClinicalMedicine. 2021 Apr;34:100801. doi: 10.1016/j.eclinm.2021.100801. Epub 2021 Mar 30. EClinicalMedicine. 2021. PMID: 33817611 Free PMC article.
-
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022. Front Public Health. 2022. PMID: 36276377 Free PMC article.
-
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24. mSphere. 2021. PMID: 34817236 Free PMC article.
-
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Benadir Region, Somalia.Vaccines (Basel). 2022 Jan 30;10(2):220. doi: 10.3390/vaccines10020220. Vaccines (Basel). 2022. PMID: 35214678 Free PMC article.
Cited by
-
Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru.Glob Epidemiol. 2023 Dec 17;7:100131. doi: 10.1016/j.gloepi.2023.100131. eCollection 2024 Jun. Glob Epidemiol. 2023. PMID: 38188037 Free PMC article.
-
COVID-19 in Latin America and the Caribbean: Two years of the pandemic.J Intern Med. 2022 Sep;292(3):409-427. doi: 10.1111/joim.13499. Epub 2022 Apr 22. J Intern Med. 2022. PMID: 35411985 Free PMC article. Review.
-
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru.EClinicalMedicine. 2021 Apr;34:100801. doi: 10.1016/j.eclinm.2021.100801. Epub 2021 Mar 30. EClinicalMedicine. 2021. PMID: 33817611 Free PMC article.
-
Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications.BMJ Glob Health. 2022 May;7(5):e008477. doi: 10.1136/bmjgh-2022-008477. BMJ Glob Health. 2022. PMID: 35618305 Free PMC article.
References
-
- Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, Aliaga-Raduan F, Carvajal-Rodriguez F, Dutschmann M, Schneider-Gasser EM, Zubieta-Calleja G, Soliz J. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respiratory Physiology & Neurobiology. 2020;277:103443. doi: 10.1016/j.resp.2020.103443. - DOI - PMC - PubMed
-
- Brault A. Santiago: Center for Mathematical Modeling, Universidad de Chile; 2021. Seroprevalence of SARS-CoV-2 in Chile.
LinkOut - more resources
Full Text Sources
Miscellaneous